Erectile dysfunction (ED) on August 2 is a disease that continues to fail to obtain or maintain an erection for satisfactory sexual intercourse. In China, the prevalence of ED among men aged 20 to 70 is about 26.1 percent. If the China statistical yearbook 2015 counts 500 million men aged 20 to 70, the number of ED patients in China is about 131 million. And published in 2015 the Chinese citizens great sex literacy survey data show that in the face of privacy problems, 11.65% of the people is not a regular treatment experience, only 6.97% of people using the regular western medicine treatment, according to the proportion, treatment of patients with about 2400 people, more than 2400, with regular western medicine treatment of only 9 million people, that is to say, there are more than 90% of patients did not receive regular treatment, who to develop such a large market?
The ED drug market jumped 26.6 percent
ED first-line treatment method is mainly oral drug therapy, clinically the most commonly used drugs is phosphodiesterase type 5 (PDE5) inhibitor, such as sildenafil, vardenafil his, tadalafil, in addition to this, there are such as morphine, o yohimbine, to boast Ming and phentolamine and other drugs; The ED second-line treatment is the injection or urethral injection in the penis. The three-wire treatment is the penis pacemaker. Oral medication is the most commonly used treatment in the current clinical practice.
M, according to data from the network ED drug use has rapidly growing market in the past two years, 2016 ED medication the national sales of 3.59 billion yuan, up 26.6% year on year, well above the national pharmaceutical market overall growth level (see figure 1).
  West Africa leads the ED market
In our country, ED oral drugs market main varieties have sildenafil, tadalafil and vardenafil and morphine, o 2016, sildenafil led ED drug market, sales accounted for 74.9% (see chart 2).
 In 1997, total sales of anti-ed drugs in the United States were less than $200 million, and mainstream use of drugs or injections of prostaglandin E1 accounted for about 70 percent of the market. In 1998, the market share of drugs such as prostaglandin E1, which was once popular, was reduced to less than 5% after the U.S. went public. The company's huge profits every year attracted many companies to the market.
A lot of bikers were attracted by the performance
As a leader in the treatment of ED drugs, wanai was approved by the FDA in 1998 to give priority reviews for erectile dysfunction, which was approved in 2005 to treat pulmonary hypertension. Over the years for the original enterprise has brought the huge wealth, while the patent expired in March 2011, but its sales peak appeared in 2012, for $2.051 billion, but with generics companies such as teva, APOTEX approach, its sales began to decline (see chart 3).
 Viagra into China for many years, the advantages of the original drugs has no rival, until September 18, 2014, wide medicine group, baiyun mountain "golden spear" officially get production approval, breaking the original medicine the situation of unify the whole country. After that, he joined the war bureau and opened the scene of the deer. In the face of huge market, domestic viagra will be able to meet different levels of consumer demand, which is good news for consumers or domestic enterprises.
Domestic viagra grabs the market
At present, there are 12 approved documents in the west of China, four of which are the original materials, and eight other companies, including Pfizer, baiyun mountain, and aipu, jiangsu province.
Viagra in China before, during and after the patent expires over two dozen domestic enterprises apply for generic, but ultimately the baiyun mountain, grabbing the sildenafil citrate API and tablets production approval documents, and for the price of less than half the original viagra viagra quickly seize market.
Viagra sales scale is still the biggest in 2016, but the market share has shrunk, baiyun mountain Mr Homemade viagra and jiangsu yabang epson of Philippines happy market expansion, Mr Market share growth of 5.9%, than the Philippines happy share is not high, but also rose by 1.6% (see chart 4). In terms of sales volume, baiyunshan jinge has been more prominent, winning the sales title for two consecutive years, with a market share of nearly 50%. The market share is not high and market performance remains to be seen.
  The retail terminal is the main market
Data shows that more than 90% of the market ED is in retail terminals, while hospital terminals account for a lower proportion (see figure 6). Compared with the second - and third-tier cities, first-tier cities Beijing, Shanghai, guangzhou high level of GDP, population density, young population is relatively high, ED drug sales of larger, three cities in 2016 ED medication combined make up about twenty percent of the overall market (see chart 7).
  The domestic ED market is dominated by retail. In other words, pharmacies are an important means of sales for such drugs, and patients in this channel are more sensitive to price. In addition, if online sales prescription drugs are released, online sales will be released, and the layout online will be a trend. Companies with existing production approvals also need to face the challenges of listing the companies that have submitted applications for viagra, such as chengdu diao and fujian guangsheng tang. To keep the retail market and gain a bigger share, the company has launched a 25mg new product regulation to meet the needs of different patients. After Mr New members of the public, according to the market performance of the past two years Mr M network prediction, with average retail prices, terminal sales is expected to reach 1.8 billion yuan, in 2017, ED drug market competition will be further intensified.
|
